The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Abstract
The goal of the study was to compare cardiovascular heart disease risk factors in women with polycystic ovary syndrome (PCOS) and matched control subjects. Women with PCOS have risk factors, including anovulation, hyperandrogenism, and insulin resistance, that suggest a male coronary heart disease risk-factor profile. A total of 206 women with PCOS were recruited by using records from a large reproductive endocrinology practice. A clinical diagnosis of PCOS was made if there was a history of chronic anovulation in association with either clinical evidence of androgen excess (hirsutism) or if total testosterone level was >2 nm/L or the luteinizing hormone/follicle-stimulating hormone ratio was greater than 2. The overall response rate for cases was 76%. A control population was obtained by using a combination of area voters’ registration tapes and directories of households. A control subject was matched to each case subject by age±5 years, race, and neighborhood. The response rate for recruitment of the first or second eligible control subject was 83.6%. The average age at initial interview was 35.9±7.4 years for case and 37.2±7.8 years for control subjects. Women with PCOS had significantly increased cardiovascular disease risk factors compared with control women. These included increases in body mass index, insulin, and triglyceride levels ( P <.001), decreased total HDL and HDL 2 levels ( P <.01), and increased total cholesterol and fasting LDL levels, waist/hip ratio, and systolic blood pressure ( P <.05). After controlling for age, body mass index, and other confounding variables, differences in total cholesterol, total HDL, HDL 2 , LDL cholesterol, and triglycerides were still significant between case and control subjects. These risk factors were especially elevated in PCOS women in the early premenopausal years compared with control women, indicating that women with PCOS should be monitored for early detection and considered for appropriate clinical interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Enzymatic Determination of Total Serum Cholesterol
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,125
Quantitative Determination of Serum Triglycerides by the Use of Enzymes
Bucolo, G., & David, H. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.5.476 · Cited by 3,188
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,250
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., & Odén, A. (1992) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349209006227 · Cited by 548
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P., Mattson, L.-A., Crona, N., & Lundberg, P.-A. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90704-m · Cited by 527
Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome
WILD, R. A., PAINTER, P. C., COULSON, P. B., CARRUTH, K. B., & RANNEY, G. B. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-946 · Cited by 482
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Odén, A., Janson, P. O., Mattson, L.-Å., Crona, N., & Lundberg, P.-A. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54892-4 · Cited by 470
The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
Wallach, E. E., Barbieri, R. L., Smith, S., & Ryan, K. J. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60060-2 · Cited by 348
NESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
Carey, A. H., Chan, K. L., Short, F., White, D., Williamson, R., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02150.x · Cited by 285
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
Guzick, D. S., Wing, R., Smith, D., Berga, S. L., & Winters, S. J. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56632-1 · Cited by 246
Self-citation5 α-reductase activity in polycystic ovary syndrome
Stewart, P. M., Edwards, C. R. W., Shackleton, C. H. L., & Beastall, G. H. (1990) · The Lancet · doi:10.1016/0140-6736(90)90664-q · Cited by 189
Clinical signs of androgen excess as risk factors for coronary artery disease
Wild, R. A., Grubb, B., Hartz, A., Van Nort, J. J., Bachman, W., & Bartholomew, M. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53699-1 · Cited by 183
Familial Clustering in the Polycystic Ovarian Syndrome
Lunde, O., Magnus, P., Sandvik, L., & Høglo, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000293493 · Cited by 177
The Polycystic Ovary Syndrome: Pathogenesis and Treatment
Barnes, R., & Rosenfield, R. L. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-5-386 · Cited by 163
Geffner, M. E., Kaplan, S. A., Bersch, N., Golde, D. W., Landaw, E. M., & Chang, R. J. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49211-3 · Cited by 158
Hyperinsulinemia in hyperthecosis of the ovaries
Nagamani, M., Dinh, T. V., & Kelver, M. E. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90676-9 · Cited by 122
Lipid and apolipoprotein abnormalities in hirsute women
Wild, R. A., Alaupovic, P., & Parker, I. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90605-x · Cited by 112
Hyperinsulinaemia, obesity, and syndrome X
Zavaroni, I., Bonini, L., Fantuzzi, M., Dall’Aglio, E., Passeri, M., & Reaven, G. M. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01031.x · Cited by 77
Slowinska-Srzednicka, J., Zgliczyński, S., Wierzbicki, M., Srzednicki, M., Stopińska-Głuszak, U., Zgliczyński, W., Soszynski, P. A., Chotkowska, E., Bednarska, M., & Sadowski, Z. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346870 · Cited by 70
5α-reductase and polycystic ovaries
Chayen, R., Laurian, L., Kisch, E. S., Goldberg, S., Hoerer, E., Stern, N., van Seters, A. P., Moolenaar, A. J., Derksen, J. J. L., Rosenfield, R. L., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)91338-b · Cited by 2
Cited by
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“The LDL-C levels in PCOS women appear to remain elevated but stable over time into the menopause (90, 209).”
BackgroundTriglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268
Metadata
- Authors
- Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K., & Kuller, L.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1995-07
- Volume
- 15
- Issue
- 7
- Pages
- 821-826
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2140122568
- Cited by
- 504
- References
- 24
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.